Literature DB >> 4395527

The effect of amantadine on the uptake of dopamine and noradrenaline by rat brain homogenates.

E A Fletcher, P H Redfern.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4395527     DOI： 10.1111/j.2042-7158.1970.tb08486.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  11 in total

Review 1.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

2.  Interactions of L-dopa and amantadine in patients with Parkinsonism.

Authors:  B Cox; G Danta; H Schnieden; G M Yuill
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-06       Impact factor: 10.154

3.  On the effect of amantadine on monoamines and their metabolites in the brain and cerebrospinal fluid.

Authors:  U K Rinne; V Sonninen; M Hyyppä
Journal:  Experientia       Date:  1972-01-15

4.  Ultrastructural evidence of amantadine and amphetamine noradrenaline releasing action.

Authors:  E Pita; N Perez
Journal:  Experientia       Date:  1977-01-15

5.  Responses of neurones in the cerebral cortex and caudate nucleus to amantadine, amphetamine and dopamine.

Authors:  T W Stone
Journal:  Br J Pharmacol       Date:  1976-01       Impact factor: 8.739

6.  Studies on the mechanism of action of amantadine.

Authors:  F Brown; P H Redfern
Journal:  Br J Pharmacol       Date:  1976-12       Impact factor: 8.739

7.  In vitro studies on the possible effects of 1-aminoadamantanes on the serotonergic system in M. Parkinson.

Authors:  W Wesemann; G Dette-Wildenhahn; H Fellehner
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

8.  Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.

Authors:  A Barbeau; H Mars; M I Botez; M Joubert
Journal:  Can Med Assoc J       Date:  1971-07-10       Impact factor: 8.262

9.  The production of an alternative laboratory model of the Parkinson syndrome using a new benzylimidoylurea derivative LON 954.

Authors:  D M Coward; N S Doggett
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

10.  Assessment of therapeutic potential of amantadine in methamphetamine induced neurotoxicity.

Authors:  Bessy Thrash-Williams; Manuj Ahuja; Senthilkumar S Karuppagounder; Subramaniam Uthayathas; Vishnu Suppiramaniam; Muralikrishnan Dhanasekaran
Journal:  Neurochem Res       Date:  2013-08-06       Impact factor: 3.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.